AI steps in to predict diabetic blindness risk
NCT ID NCT04624737
Summary
This study aimed to develop and test an artificial intelligence (AI) system to better predict the worsening of diabetic retinopathy, a common diabetes complication that can lead to vision loss. Researchers followed over 3,000 diabetic patients for up to three years, collecting eye scans and other health data to train and validate the AI tool. The goal was to create a more precise prediction system than current methods, helping eye doctors make better decisions during patient check-ups.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC RETINOPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU de NICE HÔPITAL PASTEUR 2
Nice, CS 51069_06001, Nice cedex1, France
-
Centre Broca / Mutuelle Generale
Paris, 75013, France
-
Chic Creteil
Créteil, 94010, France
-
Chu Avicenne
Bobigny, 93000, France
-
Chu Bordeaux
Bordeaux, 33000, France
-
Chu Brest
Brest, 29200, France
-
Chu Dijon
Dijon, 21000, France
-
Chu Lariboisiere
Paris, 75010, France
-
Chu Lyon Croix Rousse
Lyon, 69317, France
-
Chu Pitie Salpetriere
Paris, 75013, France
-
Clinique Monticelli
Marseille, 13008, France
-
Clinique ophtalmologique du CHU de Nantes
Nantes, 44000, France
-
Fondation Rothschild
Paris, 75019, France
-
Hôpital des 15-20
Paris, 75571, France
Conditions
Explore the condition pages connected to this study.